US Patent 10307370 Rapamycin for the treatment of lymphangioleiomyomatosis
Patent 10307370 was granted and assigned to AI Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 7, 2014
Date of Patent
June 4, 2019
Patent Applicant
Patent Application Number
15028365
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10307370 Rapamycin for the treatment of lymphangioleiomyomatosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.